Trial intelligence / Profile preview

Edematol-HF Pilot: Outpatient Tolvaptan Diuretic Management in Heart Failure

jRCTs031240104Recruiting

Start
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of tolvaptan in heart failure (HF). Primary endpoint: Change in body weight at 14 days. Started Dec 2024; status: recruiting.

02

Drugs

tolvaptan
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on jRCTs031240104.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031240104.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call